{"id":"W2413126406","doi":"","title":"Bortezomib (millennium pharmaceuticals).","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Bortezomib; Multiple myeloma; Medicine; Oncology; Proteasome inhibitor; Internal medicine; Clinical trial","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001111105,0.0001034304,0.0001661761,0.0000840281,0.00005200982,0.00001678201,0.00006250192,0.00004749813,0.001330396],"category_scores_gemma":[0.0001475611,0.00007904142,0.00007951289,0.000143715,0.00005560963,0.00005200321,0.0000324183,0.0001459487,0.0006903108],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007361332,"about_ca_system_score_gemma":0.000007319278,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001123816,"about_ca_topic_score_gemma":0.000001303363,"domain_scores_codex":[0.9987848,0.00002688365,0.0001328005,0.0002044966,0.0002994974,0.0005514727],"domain_scores_gemma":[0.999101,0.00004582443,0.0000182617,0.0002331446,0.00004244551,0.0005593497],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0001724291,0.0005766322,0.05591041,0.00004259446,0.0002087728,0.00043709,0.00003333927,2.472524e-7,0.00009622486,0.00006862883,0.04046198,0.9019917],"study_design_scores_gemma":[0.005598145,0.00005781811,0.7124221,0.000006815447,0.00008447956,0.0001038994,0.00001266304,0.001010003,0.003567454,0.00002020561,0.276991,0.0001254478],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5378671,0.01129691,0.00006530726,0.01395232,0.0004578508,0.004212481,0.00003612542,0.0004454239,0.4316666],"genre_scores_gemma":[0.9827742,0.0008912769,0.0001721315,0.00063007,0.0001803601,0.001154085,0.000009833425,0.00001792022,0.01417012],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9018662,"threshold_uncertainty_score":0.9995825,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1138465950922523,"score_gpt":0.3206849202111406,"score_spread":0.2068383251188883,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}